Zhangzhou Pientzehuang Pharmaceutical | 600436 - Ebitda

Aktienkurs
138.01
Täglich Wechseln
0.16 0.12%
Monatlich
-7.36%
Jährlich
-33.96%
Q2 Prognose
138.34




Ebitda Veränderung Datum
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Avita Medical AUD -9.69M 12.21M 2025-12
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
IQVIA Holdings USD 932M 114M 2026-03
Jiangsu Hengrui CNY 2.3B 678.46M 2025-12
Kangmei Pharma CNY 17.3M 20.56M 2025-06
Moderna USD -790M 582M 2025-12
Revvity USD 272.91M 24M 2026-03
Sh Fosun Pharma CNY 1.57B 128.23M 2025-12
Tectonic Therapeutic USD -21.18M 365K 2025-12
Viatris USD 1.05B 46.4M 2026-03
WuXi AppTec CNY 5.64B 3.31B 2026-03
Xeris Pharmaceuticals USD 25.09M 7.67M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M 2026-03